Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Pros & Cons of Combining Different Specialties Under One Roof

Gregory C. Gardner, MD, FACP  |  Issue: July 2018  |  July 19, 2018

7Crafts / shutterstock.com

7Crafts / shutterstock.com

Many rheumatology patients have complex conditions and require the added expertise of colleagues in other fields, such as pulmonology, neurology or dermatology. This is even more true when patients with complex care issues are referred to academic medical centers. At such centers, patients often travel hours for an appointment and see more than one provider.

The University of Washington is the only academic medical center in the five-state region known as WWAMI (i.e., Washington, Wyoming, Alaska, Montana and Idaho), and it serves as a referral center for these states. Several years ago, we realized that if we wanted to better serve our patients’ needs, we should make it easy for them to see their physicians and get the care they need. We gradually started a series of combined clinics with willing colleagues. At these centers, rheumatologist(s) would attend clinics in which combined expertise was often needed, including dermatology/rheumatology, nephrology/rheumatology, neuromuscular/rheumatology and interstitial lung disease (ILD)/rheumatology clinics.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Combined clinics are not a new concept. Combined dermatology/rheumatology clinics are present at many academic institutions nationally and internationally, and many have focused on the combined treatment of psoriasis and psoriatic arthritis.1 Combining expertise has also led to the development of a fellowship at Brigham and Women’s Hospital in Boston in which a rheumatologist or dermatologist can pursue a one-year fellowship in the combined dermatology/rheumatology clinic. More than 20 academic institutions participate in a research consortium based on the combined dermatology/rheumatology model of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN).2 In addition, combined clinics in other fields, such as ILD/rheumatology and myositis/rheumatology, operated for many years at the Cleveland Clinic, Louisiana State University, National Jewish Health in Denver, Johns Hopkins in Baltimore and other institutions.

Dr. Lawrence Ho (pulmonary/ILD) points out important features of an HRCT scan to Dr. Greg Gardner (rheumatology), Dr. Percy Balderia (rheumatology fellow) and Dr. Bridget Collins (pulmonary ILD).

Dr. Lawrence Ho (pulmonary/ILD) points out important features of an HRCT scan to Dr. Greg Gardner (rheumatology), Dr. Percy Balderia (rheumatology fellow) and Dr. Bridget Collins (pulmonary ILD).

Clinics combine patient care in a variety of ways. Some simply schedule patients in different clinics on the same day, with interaction by phone or electronic medical record. Multidisciplinary conferences also provide combined care. Some combined clinics have specialists in the same clinic who see patients at different times, with a post-clinic conference or workroom interaction to discuss patient-care issues.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I prefer the different-specialists, same-time strategy, in which specialists see the patient at the same time and hold a face-to-face discussion with the patient. This is what we do in most of our combined clinics. It’s the most time-consuming method, but it provides a high-quality experience for trainees, specialists and patients. How often do we rheumatologists get to see a dermatologist describing what they see on examination in real time or watch as a skilled neuromuscular neurologist does a strength examination and discusses the findings, or listen as a pulmonologist reviews a high-resolution CT scan of the chest with a patient?

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:FacilityPractice SupportWorkforce Tagged with:specialty

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease

    September 22, 2021

    Treatment with tocilizimab preserved lung function in patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) regardless of a patient’s level of lung involvement, according to a recent study.

    New Africa / shutterstock.com

    A Rheumatologist & Pulmonologist Discuss RA-ILD

    November 14, 2021

    Introduction The understanding and treatment of rheuma­toid arthritis (RA) has evolved dramatically in the past 20 years. As gains have been made in treating joint disease in RA, our understanding of the impact of extra-articular manifestations of RA, such as cardiac and lung disease—specifically interstitial lung disease (ILD)—has gradually increased. While rheumatologists increasingly appreciate the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences